Attenuation of angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by Fasudil, a Rho kinase inhibitor: Association with apoptosis

被引:0
|
作者
Wang, YX
Martin-McNulty, B
da Cunha, V
Vincelette, J
Lu, XR
Feng, QP
Halks-Miller, M
Mahmoudi, M
Schroede, M
Deng, GG
Schirm, S
Johns, A
Kauser, K
Dole, WP
Light, DR
机构
[1] Berlex Biosci, Richmond, CA USA
[2] Univ Western Ontario, London, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P253
引用
收藏
页码:E44 / E44
页数:1
相关论文
共 50 条
  • [1] Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis
    Wang, YX
    Martin-McNulty, B
    da Cunha, V
    Vincelette, J
    Lu, XG
    Feng, QP
    Halks-Miller, M
    Mahmoudi, M
    Schroeder, M
    Subramanyam, B
    Tseng, JL
    Deng, GD
    Schirm, S
    Johns, A
    Kauser, K
    Dole, WP
    Light, DR
    CIRCULATION, 2005, 111 (17) : 2219 - 2226
  • [2] Effects of Caspase Inhibitor on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice
    Yamanouchi, Dai
    Morgan, Stephanie
    Kato, Kaori
    Lengfeld, Justin
    Zhang, Fan
    Liu, Bo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (04) : 702 - U134
  • [3] Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice
    Inoue, Nao
    Muramatsu, Michiko
    Jin, Denan
    Takai, Shinji
    Hayashi, Tetsuya
    Katayama, Hiroshi
    Kitaura, Yasushi
    Tamai, Hiroshi
    Miyazaki, Mizuo
    ATHEROSCLEROSIS, 2009, 204 (02) : 359 - 364
  • [4] Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice
    Wang, Yutang
    Sargisson, Owen
    Nguyen, Dinh Tam
    Parker, Ketura
    Pyke, Stephan J. R.
    Alramahi, Ahmed
    Thihlum, Liam
    Fang, Yan
    Wallace, Morgan E.
    Berzins, Stuart P.
    Oqueli, Ernesto
    Magliano, Dianna J.
    Golledge, Jonathan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [5] Cathepsin S is essential to angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice
    Qin, Yanwen
    Shi, Guo-Ping
    Du, Jie
    CIRCULATION, 2012, 125 (19) : E710 - E710
  • [6] Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice
    Qin, Yanwen
    Cao, Xu
    Guo, Jun
    Zhang, Yaozhong
    Pan, Lili
    Zhang, Hongjia
    Li, Huihua
    Tang, Chaoshu
    Du, Jie
    Shi, Guo-Ping
    CARDIOVASCULAR RESEARCH, 2012, 96 (03) : 401 - 410
  • [7] Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
    Guo, Jia
    Zhang, Qing
    Li, Zhidong
    Qin, Min
    Shi, Jinyun
    Wang, Yan
    Ai, Wenjia
    Ju, Junjie
    Samura, Makoto
    Tsao, Philip S.
    Xu, Baohui
    BIOMOLECULES, 2024, 14 (06)
  • [8] ASB17061, a novel chymase inhibitor, prevented the development of angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice
    Tomimori, Yoshiaki
    Manno, Atsushi
    Tanaka, Taisaku
    Futamura-Takahashi, Junko
    Muto, Tsuyoshi
    Nagahira, Kazuhiro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 856
  • [9] The Rho-kinase inhibitor fasudil attenuates angiotensin II-induced cardiac hypertrophy and ventricular dysfunction in apolipoprotein E deficient mice
    Wang, YX
    da Cunha, V
    Martin-McNulty, B
    Vincelette, J
    Li, WW
    Choy, DF
    Halks-Miller, M
    Mahmoudi, M
    Schroeder, M
    Johns, A
    Light, DR
    Dole, WP
    FASEB JOURNAL, 2005, 19 (04): : A207 - A207
  • [10] Cilostazol Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E-Deficient Mice
    Umebayashi, Ryoko
    Uchida, Haruhito A.
    Kakio, Yuki
    Subramanian, Venkateswaran
    Daugherty, Alan
    Wada, Jun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (04) : 903 - 912